Ethylene Oxide & Sterilization
Ethylene Oxide (EtO) gas is one of the most common ways to sterilize medical devices, a safe, tightly controlled, highly regulated process which is critical for preventing infections and ensuring…
Ethylene Oxide
Learn more about our Ethylene Oxide & Sterilization work.
Medical Device Industry Challenges Misleading Information Campaign About the Safety and Use of Ethylene Oxide in Georgia
WASHINGTON, D.C. – The CEO of the world’s largest medical technology trade association (AdvaMed®) and the CEO of Georgia Bio, a trade association representing life sciences companies in Georgia, have teamed up…
EPA Ethylene Oxide Value at Odds with Public Health, Best Science
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) again urged the U.S. EPA to abandon its ethylene oxide (EtO) risk assessment value for one that is more feasible, based on the…
AdvaMed® Comments on National Emission Standards for Hazardous Air Pollutants: Miscellaneous Organic Chemical Manufacturing Residual Risk and Technology Review
AdvaMed® provided these comments in response to the U.S. Environmental Protection Agency (EPA) publishing the proposed rulemaking concerning the residual risk and technology review (RTR) for the National Emission Standards…
Medical Device Manufacturers Raise Public Health Concerns Over EPA Ethylene Oxide Value
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither…
AdvaMed® Comments on National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Commercial Sterilization and Fumigation Operations
AdvaMed® provided these comments in response to the U.S. Environmental Protection Agency (EPA) soliciting information that will aid in potential future revisions to the Ethylene Oxide Emission Standards for Sterilization…
AdvaMed® Statement on EtO Air Testing by EPA
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement today from President and CEO Scott Whitaker following release of air testing data from the Environmental Protection Agency…